Table 1.
Codon nucleotide composition in the examined region of loop L1
| Serotype | T (U) (%) | C (%) | A (%) | G (%) | Examined region (nt) | T-1 (%) | C-1 (%) | A-1 (%) | G-1 (%) | pos #1 (nt) | T-2 (%) | C-2 (%) | A-2 (%) | G-2 (%) | pos #2 (nt) | T-3 (%) | C-3 (%) | A-3 (%) | G-3 (%) | pos #3 (nt) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FAdV-1 | 18.1 | 30.1 | 23.9 | 27.9 | 519.0 | 13 | 22.3 | 29.1 | 36.0 | 175.0 | 24 | 27.3 | 31.4 | 16.9 | 172.0 | 17 | 40.7 | 11.0 | 30.8 | 172.0 |
| FAdV-2/11-D | 19.7 | 30.3 | 26.1 | 23.9 | 522.0 | 16 | 16.7 | 31.0 | 36.8 | 174.0 | 23 | 32.2 | 31.0 | 13.8 | 174.0 | 21 | 42.0 | 16.1 | 21.3 | 174.0 |
| FAdV-4 | 16.8 | 34.4 | 23.5 | 25.3 | 506.0 | 18 | 18.1 | 31.0 | 32.7 | 171.0 | 19 | 35.1 | 31.5 | 14.3 | 168.0 | 13 | 50.3 | 7.8 | 28.7 | 167.0 |
| FAdV-5 | 19.8 | 30.1 | 26.0 | 24.1 | 531.0 | 15 | 16.4 | 37.9 | 30.5 | 177.0 | 21 | 35.6 | 28.2 | 14.7 | 177.0 | 23 | 38.4 | 11.9 | 27.1 | 177.0 |
| FAdV-7 | 17.9 | 30.9 | 26.5 | 24.8 | 525.0 | 15 | 20.0 | 33.7 | 30.9 | 175.0 | 22 | 32.0 | 29.7 | 16.6 | 175.0 | 17 | 40.6 | 16.0 | 26.9 | 175.0 |
| FAdV-8a | 17.9 | 30.9 | 24.2 | 27.0 | 525.0 | 14 | 17.7 | 32.6 | 35.4 | 175.0 | 22 | 30.9 | 28.6 | 18.3 | 175.0 | 17 | 44.0 | 11.4 | 27.4 | 175.0 |
| FAdV-8b | 18.1 | 29.3 | 27.0 | 25.5 | 525.0 | 15 | 18.9 | 30.9 | 34.9 | 175.0 | 21 | 31.4 | 31.4 | 16.0 | 175.0 | 18 | 37.7 | 18.9 | 25.7 | 175.0 |
| Average | 18.3 | 30.8 | 25,. | 25.5 | 521.9 | 15 | 18.6 | 32.3 | 33.9 | 174.6 | 22 | 32.1 | 30.3 | 15.8 | 173.7 | 18 | 41.9 | 13.3 | 26.8 | 173.6 |
FAdV-7 - 5/10j strain which was chosen for the study is highlighted in bold
T (U), thymine (uracyl); C, cytosine; A, adenine; G, guanine. Nucleotide occurrence in the examined region of the L1 loop and in the first (T-1, C-1, A-1, G-1), second (T-2, C-2, A-2, G-2), and third (T-3, C-3, A-3, G-3) position of the codon